Anxiety grows over telemedicine flexibility extension
The Hill
OCTOBER 24, 2024
Since 2020, the Department of Health and Human Services and the Drug Enforcement Administration (DEA) have allowed physicians to prescribe schedule II to V controlled substances without in-person medical evaluations. These restrictions would be detrimental to patients and a barrier to accessing care,” a letter led by Sens.
117 
Let's personalize your content